The markets traded higher during the midday with the Dow adding 16 points to 16,797 as the Federal Reserve met. Nasdaq rose 17 points to 4,338.
On the upside
GW Pharmaceuticals (Nasdaq: GWPH) reported promising preliminary data for its treatment-resistant epilepsy therapy Epidiolex.
Amira Nature Foods (NYSE: ANFI) reported sharply higher fourth quarter earnings and revenue that surpassed analyst expectations.
SolarCity (Nasdaq: SCTY) will purchase solar panel maker Silveo.
On the downside
Boston Scientific (Nasdaq: BSX) said that it would be opportunistic when exploring possible acquisitions.
Investors locked in profits on Magnegas (Nasdaq: MNGA).
Profit taking weighed down shares of Sinclair Broadcast Group (Nasdaq: SBGI).
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 rose 3 points to 1940. Bitcoin edged up $3.24 or 0.54% to $596.45.